跳至主要内容
临床试验/NCT06369168
NCT06369168已完成不适用

Effect and Effectiveness of Auricular Acupuncture in Improving Hot Flashes During Adjuvant Endocrine Therapy in Women With Breast Cancer: A Randomized Controlled Study

Kliniken Essen-Mitte2 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2024年6月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
107
试验地点
2
主要终点
subscale somato-vegetative symptoms of the Menopause Rating Scale (MRS)

研究概览

简要总结

With this clinical trial we investigate whether auricular acupuncture during adjuvant endocrine therapy has an improving effect on hot flashes, which are often perceived as psychologically and physically stressful in self-assessment of women with breast cancer.

Empirical studies indicate that body acupuncture has positive effects on hot flashes. As auricular acupuncture offers a number of advantages over body acupuncture, a three-armed randomised controlled research design is being used to investigate whether hot flashes caused by endocrine therapy are also reduced by ear acupuncture. Balanced ear acupuncture will be compared with NADA ear acupuncture in terms of efficacy and effectiveness. In addition, the effects of the two forms of therapy on the patients' individual quality of life, fatigue, stress perception and sleep quality will be analysed.

详细描述

In Germany, one in eight women will develop breast cancer in her lifetime, with a relative 5-year survival rate of 88%. Around 70 % of breast cancer cases are hormone receptor positive. Adjuvant endocrine therapy is recommended to reduce the risk of recurrence.The results of a systematic review show that around 52.4 % to 84.8 % of patients adhere to the treatment. It was also shown that non-adherence to treatment has a negative impact on the risk of breast cancer recurrence and the development of distant metastases, as well as on mortality. Lack of adherence to treatment is related, among other things, to the side effects of endocrine therapy, which significantly reduce quality of life. In particular, musculoskeletal syndrome and sleep disorders lead to discontinuation of endocrine treatment with an aromatase inhibitor. Many patients also suffer from hot flashes, sexual dysfunction, weight gain, bone density loss, depression, cognitive dysfunction and fatigue.

The study focuses on hot flashes, which have a negative impact on sleep and promote symptoms of fatigue. Due to the endocrine therapy, the symptoms are usually more pronounced than the menopause-related symptoms. However, oestrogen-based hormone replacement therapy is contraindicated, while non-hormonal medication such as venlafaxine or gabapentin often have serious side effects. An alternative is body acupuncture, which can decrease hot flashes in women with breast cancer. One of the advantages of acupuncture compared to drug treatments is that it is considered having very few side effects.

With the help of a three-armed randomized controlled research design, this study aims to investigate the efficacy and effectiveness of balanced ear acupuncture compared to NADA ear acupuncture in the treatment of hot flashes caused by endocrine therapy. In addition, the effects of the two forms of therapy on the individual quality of life, fatigue, stress perception and sleep quality of the patients will be analyzed.The respective results will be compared with those of a control group that did not receive acupuncture during the observation period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • histologically confirmed diagnosis of non-metastatic hormone receptor-positive breast CA (TNM stage I-III) under adjuvant endocrine therapy
  • hot flashes, measured with the MRS (Menopause Rating Scale)
  • willingness to participate in the study and signed informed consent

排除标准

  • ongoing or planned chemotherapy, radiotherapy, follow-up treatment or reconstructive plastic surgery during the study period
  • severe physical or psychopharmacologically treated psychiatric comorbidity, due to which a patient is unable to participate in the study
  • pregnancy
  • participation in other clinical trials with behavioural, psychological or complementary medicine, psychological or complementary medical interventions
  • regular use of barbiturates, antidepressants, abuse of drugs and/or alcohol
  • ongoing acupuncture treatment
  • lack of ability to complete the questionnaires independently
  • operations or infections in the area to be acupunctured

结局指标

主要结局

subscale somato-vegetative symptoms of the Menopause Rating Scale (MRS)

时间窗: Baseline, end of the intervention (6 weeks after the beginning), three months follow-up

measure for hot flashes, from minimum 0 to maximum 4, with the maximum being the worst outcome

次要结局

  • perceived stress questionnaire (PSQ)(Baseline, end of the intervention (6 weeks after the beginning), three months follow-up)
  • big five inventory (BFI)(current condition at baseline, end of the intervention (6 weeks after the beginning), three months follow-up)
  • Menopause Rating Scale (MRS) total score(Baseline, end of the intervention (6 weeks after the beginning), three months follow-up)
  • functional assessment of cancer therapy - breast (FACT-B)(Baseline, end of the intervention (6 weeks after the beginning), three months follow-up)
  • insomnia severity index (ISI)(Baseline, end of the intervention (6 weeks after the beginning), three months follow-up)
  • intensity and degree of impairment due to hot flashes on a 100mm visual analogue scale(current condition at baseline, end of the intervention (6 weeks after the beginning), three months follow-up)
  • Psychological symptoms and urogenital symptoms subscales of the MRS(Baseline, end of the intervention (6 weeks after the beginning), three months follow-up)
  • Expected effect of the respective intervention on a 100mm visual analogue scale(baseline, end of the intervention (6 weeks after the beginning), three months follow-up)
  • adverse events (AEs)(current condition at baseline, end of the intervention (6 weeks after the beginning), three months follow-up)

研究者

发起方
Kliniken Essen-Mitte
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验